The legislative pressure on mandatory GMO labeling continues to build, at least on the state front, as...
|
Among recent warning letters sent by the US Food and Drug Administration to supplement manufacturers one stood...
|
A team of researchers may have taken a large step towards designing the optimal synbiotics for gut...
|
Live from VitaFoods 2013
Adam Ismail
Executive Director, GOED
|
Association to hold seminar on 'The Non-GMO Future'
Dietary supplement manufacturers need to consider the implications of possible GMO labeling initiatives, with the issue more...
|
The Center for Science in the Public Interest (CSPI) is threatening litigation against Bayer for alleged “deceptive practices...
|
The five associations representing the dietary supplement industry have asked the Food and Drug Administration (FDA) to...
|
Adverse Events
In recent years, the complexity of bringing products to market has grown.
The supplement market and life science industry is a quickly evolving, innovative space with both small and established players competing to bring new, life-enhancing innovations to market.
For instance:
There are seven major opportunities for improving quality within the industry.
Finding ways to increase revenues, while maintaining compliance and high levels of product safety is essential to maintaining a competitive edge.
Serious adverse event reports related to new products use have outpaced industry growth by 8% per annum since 2001 and Quality risk is not evenly distributed across the industry.
Posted by Jon Nugent
27 April 2012 | 14h13